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Abstract LmrA confers multidrug resistance to Lactococcus
lactis by mediating the extrusion of antibiotics, out of the bac-
terial membrane, using the energy derived from ATP hydrolysis.
Cooperation between the cytosolic and membrane-embedded do-
mains plays a crucial role in regulating the transport ATPase
cycle of this protein. In order to demonstrate the existence of a
structural coupling required for the cross-talk between drug
transport and ATP hydrolysis, we studied speci¢cally the dy-
namic changes occurring in the membrane-embedded and cyto-
solic domains of LmrA by combining infrared linear dichroic
spectrum measurements in the course of H/D exchange with
Trp £uorescence quenching by a water-soluble attenuator.
This new experimental approach, which is of general interest
in the study of membrane proteins, detects long-range confor-
mational changes, transmitted between the membrane-embedded
and cytosolic regions of LmrA. On the one hand, nucleotide
binding and hydrolysis in the cytosolic nucleotide binding do-
main cause a repacking of the transmembrane helices. On the
other hand, drug binding to the transmembrane helices a¡ects
both the structure of the cytosolic regions and the ATPase
activity of the nucleotide binding domain.
) 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Multidrug resistance is often mediated by membrane trans-
port proteins and results in the ine⁄ciency of cancer and
infectious disease treatments [1,2]. Some of these proteins
that transport a broad spectrum of structurally unrelated cy-
totoxic drugs act as ATP-driven e¥ux pumps. In cancer cells,
multidrug resistance to chemotherapy mainly results in the
overexpression of ABC (ATP binding cassette) transporters
like Pgp (P-glycoprotein) [3] and MRP (multidrug resis-
tance-associated) proteins [4]. LmrA, from Lactococcus lactis,
also belongs to the ABC superfamily and its expression results
in an increased bacterial resistance to di¡erent antibiotics [5].
This protein is a structural and functional homologue of the
mammalian Pgp. Indeed, both proteins have a similar drug
and modulator speci¢city [6]. Furthermore, LmrA can even
functionally complement Pgp in human ¢broblast cells [7].
ABC transporters are composed of four core domains [8].
Two of these domains are hydrophobic and located within the
membrane. Hydropathy models predict that each of these
domains contains six K-helices. Two other domains are hydro-
philic and contain the NBDs (nucleotide binding domain)
which hydrolyze ATP. Pgp contains these four domains in
one polypeptide chain [9,10]. In contrast, LmrA appears to
be half a transporter, only containing one hydrophobic and
one hydrophilic domain [6]. However, it is functionally active
as a homodimer [11]. Pgp and LmrA share a high sequence
homology, notably in their NBDs, which is a general property
of all ABC transporters. Furthermore, their hydrophobic do-
mains implicated in drug recognition and transport [12,13]
also share a high level of homology [6]. The use of polarized
infrared spectroscopy demonstrated that the transmembrane
segments of LmrA are made of K-helices oriented perpendic-
ular with respect to the membrane [14]. Three-dimensional
crystals of MsbA [15] and BtuCD [16] have con¢rmed that
the helical nature of the membrane-embedded domain is a
general characteristic of ABC transporters.
A transport model, based on transport measurements, drug
equilibrium determinations and photoa⁄nity labelling, pro-
poses that LmrA functions by an alternating two-site mecha-
nism [11]. In this model, LmrA passes through two con¢gu-
rations, containing a high-a⁄nity, inside-facing, drug binding
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site and a low-a⁄nity, outside-facing, drug release site and the
interconversion of these two con¢gurations is ATP-dependent.
A similar mechanism has been proposed for Pgp [17^20]. This
model requires the existence of a structural cooperation be-
tween the membrane and cytosolic domains leading to the
coupling mechanism between the hydrolysis process and the
transport of drug. The characterization of such a structural
coupling is of clinical interest. Indeed, compounds perturbing
interactions between the cytosolic and membrane-embedded
domains may interfere with the transport function of LmrA
and modulate multidrug resistance phenomena in general.
The main goal of the present study is to investigate whether
long-range conformational changes are transmitted between
the membrane and cytosolic domains of LmrA and to char-
acterize their nature. For this purpose, we took advantage of
two complementary methods to detect speci¢c structural
changes occurring in either the membrane-embedded or cyto-
solic regions of LmrA. On the one hand, Trp £uorescence
quenching by acrylamide, an aqueous quencher, was used to
observe changes occurring in the cytosolic regions in the pres-
ence of drug or during the hydrolysis process. On the other
hand, monitoring the infrared linear dichroic spectra in the
course of H/D exchange made it possible to focus exclusively
on the membrane-embedded K-helices and to observe how
they are a¡ected by ATP/drug binding and ATP hydrolysis.
Experiments were carried out in the presence of di¡erent li-
gands in order to characterize structural intermediates in-
volved in the transport process. First, daunorubicin (DNR),
a cytotoxic drug well transported by LmrA, was used to iden-
tify the structural e¡ect due to drug binding. Second, ATP
and its non-hydrolyzable analogue ATPQS (adenosine-5P-O-
(thiotriphosphate)) [21] were used to discriminate between
the structural e¡ects mediated by ATP hydrolysis and ATP
binding respectively.
2. Materials and methods
2.1. Materials
ATP, ATPQS and DNR were from Sigma. D2O was from Merck,
Ni-NTA (Ni2þ-nitrilotriacetic acid) resin from Qiagen, Bio-Beads
SM2 from Bio-Rad, polycarbonate ¢lters from Avestin and DDM
(dodecyl-L-D-maltoside) from Anatrace. Escherichia coli lipids and
L-K-phosphatidylcholine from egg yolk were purchased from Avanti
Polar Lipids.
2.2. Bacterial strains and expression vector
L. lactis subsp. lactis strain NZ9000 was used as a host for the
LmrA expression vector used in this work [22]. The pCHL LmrA
vector [7] was used in this study after introduction of an NcoI site
upstream of the hexahistidine tag and an XbaI site at the 3P end of
LmrA. This plasmid was transformed into L. lactis NZ9000 and the
transformants were screened by restriction analysis of the plasmids
[22].
2.3. Puri¢cation
The puri¢cation of LmrA was carried out essentially as described
previously [22]. Brie£y, inside-out membrane vesicles, containing over-
expressed LmrA, were solubilized in 50 mM potassium phosphate, pH
8, containing 10% (v/v) glycerol, 100 mM NaCl and 1% (w/v) DDM.
After 30 min incubation at 4‡C, the insoluble material was removed
by centrifugation. The supernatant was mixed and incubated for 1 h,
at 4‡C, with Ni-NTA agarose (approximately 8 mg LmrA/ml resin),
which was pre-equilibrated in bu¡er A (50 mM potassium phosphate,
pH 8, 100 mM NaCl, 10% glycerol and 0.05% DDM) plus 10 mM
imidazole. The resin was transferred to a Bio-spin column (Bio-Rad)
and washed with 20 column volumes of bu¡er A containing 10 mM
imidazole, and subsequently with 40 column volumes of bu¡er A
(pH 7) plus 40 mM imidazole. The protein was eluted with bu¡er A,
pH 7, supplemented with 150 mM imidazole.
2.4. Reconstitution
Liposomes of acetone/ether-washed E. coli lipids and L-K-phospha-
tidylcholine from egg yolk, in a ratio (w/w) of 3:1, were made by
dissolving lipids in 50 mM potassium phosphate, pH 7, at a ¢nal
concentration of 20 mg/ml. Unilamellar liposomes with relatively ho-
mogeneous size were prepared by freezing in liquid nitrogen and slow
thawing at room temperature followed by extrusion of the liposomes
12 times through a 400-nm polycarbonate ¢lter. The reconstitution of
LmrA into liposomes was carried out essentially as described in [22]
using a (w/w) protein:lipid ratio of 1/10. The resulting proteolipo-
somes exhibited ATP-dependent drug transport, inhibited by chemo-
sensitizers [22]. Proteoliposomes were resuspended to a ¢nal protein
concentration of 1 mg/ml in 3 mM potassium HEPES, pH 7.4.
2.5. Attenuated total re£ection Fourier transform infrared spectroscopy
(ATR-FTIR)
ATR-FTIR spectra were recorded, at room temperature, on a
Bruker IFS55 FTIR spectrophotometer equipped with a liquid nitro-
gen-cooled mercury^cadmium^telluride detector at a nominal resolu-
tion of 2 cm31, and encoded every 1 cm31. The spectrophotometer
was continuously purged with air dried on a FTIR purge gas gener-
ator 75-62 Balston (Maidstone, UK) at a £ow rate of 5.8 l/min. The
internal re£ection element (ATR) was a germanium plate (50U20U2
mm) with an aperture angle of 45‡, yielding 25 internal re£ections
[23].
2.5.1. Sample preparation. The sample contained 20 Wg of recon-
stituted LmrA. For measurements in the presence of DNR, 2.5 Wl of a
2 mM solution was added to the proteoliposomes. In these conditions,
the molar ratio of LmrA over DNR is 1/14. For measurements in the
presence of MgATPQS or MgATP, 0.5 Wl of a 3 mM solution was
added to reach a molar ratio of LmrA over nucleotides of 1/5. Thin
¢lms of oriented multilayers were then obtained by slowly evaporating
the sample on one side of the ATR plate, under a stream of nitrogen
[24]. It has been shown that after resuspension in 3 mM HEPES pH
7.4, no loss of ATPase activity was observed, con¢rming that ¢lm
preparation does not alter the protein conformation and activity.
The ATR plate was then sealed in a universal sample holder.
2.5.2. Orientation of the secondary structures. The molecular ori-
entation was determined by infrared ATR spectroscopy as previously
described [25]. Spectra were recorded with parallel and perpendicular
polarized light with respect to the incidence plane. Dichroic spectra
were computed by subtracting the perpendicularly polarized spectrum
from the parallelly polarized spectrum. The subtraction coe⁄cient was
chosen so that the area of the lipid ester band at 1740 cm31 equals
zero on the dichroic spectrum, in order to take into account the
di¡erence in the relative power of the evanescent ¢eld for each polar-
ization as described before [25]. An upward deviation on the dichroic
spectrum indicates a dipole oriented preferentially near a normal to
the ATR plate. Conversely, a downward deviation on the dichroic
spectrum indicates a dipole oriented closer to the plane of the ATR
plate [23]. The dichroic ratio RATR is de¢ned as the ratio of the amide
I area recorded for the parallel polarization (Ae) and for the perpen-
dicular polarization (AP) :
RATR ¼ Ae=AP
In ATR, the dichroic ratio for an isotropic sample Riso is di¡erent
from unity and is computed on the basis of the area of the lipid ester
band (1762^1700 cm31) [26].
2.5.3. H/D exchange kinetics of the oriented domain of the
protein. Films containing 20 Wg of reconstituted LmrA were pre-
pared on a germanium plate as described above. Nitrogen was satu-
rated with D2O by bubbling in a series of three vials containing D2O.
Spectra were recorded with the incident light polarized perpendicular
and parallel with respect to the incident plane for each time point of
the kinetics. The dichroic spectrum was then computed by subtracting
the perpendicular polarized spectrum from the parallel one, as de-
scribed previously. Before starting the deuteration, four spectra of
the sample were recorded for each polarization to test the stability
of the measurements. At zero time, the D2O-saturated N2 £ux, at a
£ow rate of 100 ml/min (controlled by a Brooks £ow meter), was
connected to the sample. For each kinetic time point, 24 scans were
recorded and averaged at a resolution of 2 cm31 for each polarization.
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The signal from the atmospheric water was subtracted from each
spectrum [27]. Previous experiments have demonstrated that the di-
chroic spectrum of LmrA arises only from the oriented membrane
helices [14], as the cytoplasmic domain possesses no speci¢c orienta-
tion. In this case, the shift of the amide I dichroic spectrum during the
time of exposure to D2O allowed us to evaluate speci¢cally the ex-
change rate of the transmembrane helices. This shift occurred between
1658 cm31, corresponding to the H form of K-helices, and 1648 cm31,
corresponding to the D form of K-helices [14].
2.6. ATP hydrolysis
ATPase activity was determined by measuring the release of inor-
ganic phosphate (Pi) from ATP, using a colorimetric method adapted
from [28]. The liberation of Pi was quanti¢ed after 1 h incubation of
the samples (containing 1^2 Wg of LmrA reconstituted into liposomes,
in the presence or absence of 10 WM DNR) in the presence of 3 mM
MgATP at 37‡C. The e¡ect of the free hydrolysis of MgATP and of
DNR on the colorimetric assay was subtracted.
2.7. Tryptophan £uorescence quenching experiments
Acrylamide quenching experiments were carried out on an SLM
Aminco 8000 £uorimeter at an excitation wavelength of 290 nm to
reduce the absorbance of acrylamide. Acrylamide aliquots were added
from a 3 M solution to the proteoliposome suspension containing 6.5
Wg of reconstituted LmrA and the various ligands. The ¢nal concen-
trations for DNR and nucleotides were 10 WM and 3 mM, respec-
tively. Tryptophan £uorescence intensities were measured at 332 nm
after each addition of quencher. All measurements were carried out at
room temperature. Control experiments established that no emission
of DNR occurred at 332 nm if excited at 290 nm [29]. Acrylamide
quenching data were analyzed according to the Stern^Volmer equa-
tion for collisional quenching [30] :
F0=F ¼ 1þ K ½Q
where F0 and F are the £uorescence intensities in the absence and
presence of quencher, [Q] is the molar concentration of quencher,
and K is the Stern^Volmer quenching constant. Data were subjected
to a linear ¢t up to 80 mM acrylamide. Above this concentration, the
static quenching by acrylamide causes a deviation from linearity in
Stern^Volmer plots.
3. Results
3.1. Restructuring of the membrane-embedded domain of LmrA
during its catalytic cycle
Polarized ATR-FTIR spectroscopy is one of the best tools
available to characterize the structure (secondary structure
and orientation) of the membrane-embedded domain of mem-
brane proteins. The method is based on the fact that the
infrared light absorbed by a chemical bond is maximal if its
dipole transition moment is parallel to the electric ¢eld com-
ponent of the incident light. By measuring the spectral inten-
sity while turning the incident light electric ¢eld orientation
with a polarizer, it is possible to obtain information about the
orientation of the dipoles [23]. Orientation of secondary struc-
tures can be determined according to the orientation of the
amide CNO dipole with respect to the membrane. Two spec-
tra are recorded with the incident light polarized parallel and
perpendicular with respect to the membrane plane. A qualita-
tive analysis of the orientation of secondary structures with
respect to the membrane is obtained by subtracting the P
from the e polarized spectrum. In the absence of any orienta-
tion, a straight horizontal line is expected in the amide I
region of the dichroic spectrum [23]. Positive deviations indi-
cate a transition dipole oriented close to perpendicular to the
membrane, while negative deviations indicate a dipole align-
ment approximately in the membrane plane. For instance, a
transmembrane K-helix will give rise to a positive deviation as
its amide I dipole is parallel to its long axis. The dichroic
spectrum of LmrA shows an upward deviation at 1659
cm31, characteristic of K-helices perpendicular to the mem-
brane [14] (Fig. 1). As con¢rmed by proteolysis studies, these
helices compose the membrane-embedded domain of LmrA
[14]. No speci¢c orientation of the cytosolic domain of
LmrA with respect to the membrane was detected. These ob-
servations demonstrated that only the transmembrane helices
contribute signi¢cantly to the dichroism.
To characterize the ligand-induced restructuring of the
membrane-embedded domain, we ¢rst analyzed the e¡ect of
drug binding and ATP hydrolysis on the main orientation of
the transmembrane helices. Quantitative evaluation of the he-
lix mean tilt requires the evaluation of the dichroic ratio RATR
of amide I and of Riso, which is the dichroic ratio measured
for a transition dipole either spatially disordered or oriented
at the magic angle [26]. As indicated in Section 2, and as
developed in [26], Riso is computed on the basis of the lipid
Fig. 1. Polarized infrared and dichroic spectra of LmrA. ATR-
FTIR spectra of 20 Wg of LmrA recorded with incident light polar-
ized parallel (A) or perpendicular (B) to the incident plane. The di-
chroic spectrum (C) is obtained by subtracting A from B. Spectrum
C has been increased four-fold for clarity. Inset shows the superim-
position of these three spectra.
Table 1
Dichroic ratio RATR of the amide I band of LmrA determined in
the absence and presence of substrates
Substrate Dichroic ratio
Riso RATR
None 1.5 S 0.1 1.9S 0.1
+DNR 1.4S0.1 1.9S 0.1
+DNR+MgATPQS 1.5S 0.1 1.8S 0.1
+DNR+MgATP 1.5S0.1 1.9S 0.1
RATR and Riso (for the lipid X(CNO)) were calculated as described
in Section 2.
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ester band (between 1800 and 1700 cm31, Fig. 1). We com-
pared the dichroic ratio RATR obtained in the presence and
absence of di¡erent ligands. RATR = 1.9S 0.1, which corre-
sponds to a main orientation of the helices perpendicular to
the membrane (Table 1). Table 1 shows that RATR does not
change signi¢cantly in the presence of DNR, MgATPQS or
MgATP. With a standard deviation of 0.1 for the RATR de-
termination, only changes in the helix tilt of more than 3‡ are
detected. Consequently, the main tilt of the membrane-em-
bedded helices seems una¡ected upon drug or ATP binding
or during ATP hydrolysis.
Although the mean tilt of the membrane helices is not
modi¢ed upon interaction with substrates, rotation or trans-
lation of helices may modify their general packing. These
conformational changes may a¡ect their accessibility towards
the external medium but also the strength of the H bonds
stabilizing their structure, two parameters which a¡ect H/D
exchange kinetics [31]. While the amide II area decrease as a
function of time can be used to evaluate the global exchange
kinetic of the protein, the amide II band displays only low
dichroism which makes it useless for the determination of the
exchange kinetic of LmrA membrane-embedded helices [32].
In contrast, the maximum of the dichroism of amide I shifts
between the H form of K-helices (maximum at V1658 cm31)
and the D form (maximum at V1648 cm31) during the time
of exposure to D2O (Fig. 2). Consequently, the stability and
accessibility towards the external medium of the transmem-
brane segments of LmrA can be estimated by following the
shift of the maximum of the dichroic amide I during the time
of exposure to D2O.
Fig. 3 shows that the dichroic amide I shift occurs between
1658 and 1652 cm31 in the protein alone. Binding of DNR
mediates a slight modi¢cation of the amide I shift (from 1658
cm31 to 1653 cm31). It demonstrates that drug binding medi-
ates a conformational change in the transmembrane helices.
The decrease of the amide I shift means that the packing of
the transmembrane helices has changed in a way that leads to
a higher strength of their H bonds, corresponding to a more
rigid structure, or to a reduced accessibility towards the sol-
vent of the K-helices. In the presence of DNR and MgATPQS,
the amide I shift is identical to that observed in the absence of
ligand. We can reject the possibility that nothing happens
when DNR and MgATPQS are added together. Indeed, an
ATP-dependent drug transport is detectable in our sample
[22], which means that DNR and ATP are able to bind simul-
taneously to LmrA. Furthermore, we have demonstrated that
DNR and MgATPQS, added separately, induce a structural
modi¢cation of LmrA (see [33] for the structural e¡ect medi-
ated by MgATPQS). Consequently, when added together, both
structural e¡ects must be observed. The amide I shifts in the
presence of DNR alone or DNR/ATPQS are di¡erent, which
means that a structural e¡ect due to ATP binding is indeed
observed on the transmembrane helices. The average stability
and accessibility towards the solvent of the membrane-em-
bedded domain is, however, equivalent to that before the in-
teraction with ligands. Coaddition of DNR and MgATP
causes an amide I shift from 1658 cm31 to 1649 cm31 reveal-
ing that the transmembrane helices undergo an important
structural change that decreases the strength of their H bonds,
corresponding to a more £exible structure, or increases their
accessibility towards the external medium.
First, these results demonstrate that the transmembrane
domain of LmrA is not static as it undergoes several confor-
mational changes in the presence of ligands. Second, our ob-
servations provide evidence that ATP binding and hydrolysis
mediate long-range conformational changes transmitted from
the cytosolic NBD to the membrane-embedded domain of
LmrA. Electron cryo-microscopy of two-dimensional crystals
Fig. 2. Dichroic spectra of LmrA during the H/D exchange kinetics.
Spectra of 20 Wg of LmrA recorded as a function of deuteration
time. Spectrum at the bottom was recorded before deuteration. The
other spectra were recorded at intermediate times (4, 11, 18, 42 min
respectively).
Fig. 3. Evolution of the amide I maximum of the dichroic spectrum
as a function of the deuteration time. b, no substrate added; S,
DNR; 8, MgATPQS+DNR; R, MgATP+DNR. The curves are
the means of at least three experiments. The error bars represent
the standard deviation.
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of Pgp, the eukaryotic homologue of LmrA, have also dem-
onstrated important repacking of its transmembrane K-helices
during the transport ATPase cycle [20]. The fact that the
RATR of the transmembrane helices of LmrA is not modi¢ed
in the presence of substrates means that the restructurings of
the membrane-embedded domain do not modify the global tilt
of the transmembrane helices. Consequently, rotation or
translation movements of the K-helices within the membrane
may be involved in these restructurings of the membrane-em-
bedded domain. Biochemical evidence of such rotation of
transmembrane K-helices of Pgp [20,34] and ions channels
[35,36] has been previously reported.
3.2. Identi¢cation of restructuring occurring speci¢cally in the
cytosolic regions of LmrA during its catalytic cycle
LmrA contains ¢ve Trp residues, all predicted in extramem-
brane domains [6]. Two are located in cytoplasmic loops con-
necting helices 2 and 3 and helices 4 and 5. A third one is
located in the extracellular loop connecting helices 3 and 4.
Two others are located in the cytosolic loop following helix 6
and containing the NBD. As the protein is reconstituted in an
inside-out con¢guration [14], only the four Trp localized in
cytoplasmic loops are accessible to the aqueous quencher ac-
rylamide. Consequently, the accessibility of these Trp to the
aqueous medium makes it possible to investigate the behavior
of the cytosolic regions of LmrA upon binding of DNR/ATP
and during ATP hydrolysis. The Trp exposure to the external
solvent was determined by monitoring the £uorescence inten-
sity in the presence of increasing concentrations (0^80 mM) of
the aqueous quencher acrylamide [37]. DNR was added to a
¢nal concentration of 10 WM to LmrA reconstituted into lipo-
somes in the presence or absence of 3 mM MgATP or
MgATPQS.
Stern^Volmer plots of Trp £uorescence quenching by acryl-
amide are shown in Fig. 4. DNR binding leads to a decreased
accessibility of at least some Trp to the aqueous medium
providing strong evidence that drug binding in£uences the
structure of cytosolic regions of LmrA and that a conforma-
tional change is transmitted from the membrane-embedded K-
helices to the cytosolic domains. Upon coaddition of DNR
and MgATPQS, the average Trp accessibility is similar to that
observed in the absence of ligand. As discussed for H/D ex-
change experiments carried out in the presence of DNR and
MgATPQS, we can reject the possibility than nothing happens
in this situation and conclude that ATP binding a¡ects the
structure of some extramembrane segments of LmrA. Upon
coaddition of MgATP and DNR, the accessibility of some
Trp to the aqueous environment is strongly enhanced, dem-
onstrating that some cytosolic segments become highly acces-
sible to the aqueous environment.
To investigate whether the tertiary structure modi¢cation
mediated by DNR binding in cytosolic segments of LmrA
a¡ects directly the ATPase activity of the NBD, ATP hydro-
lysis activity was measured in the presence of 10 WM DNR.
DNR binding stimulates the ATPase activity of reconstituted
LmrA from 200S20 to 300S 20 nmol/min/mg.
4. Discussion
Transport of drugs by LmrA implicates their extrusion
from the membrane binding sites into the extracellular envi-
ronment using the energy derived from ATP hydrolysis. Sev-
eral conformational changes are likely to be involved in this
process. Reorganization of the drug binding site, altering its
exposure to the membrane or aqueous environment and its
drug a⁄nity, seems to be essential to facilitate drug binding
and subsequent release. The existence of two cooperative drug
binding sites on LmrA has been suggested in [11] : a low-af-
¢nity one on the outer membrane surface allosterically
coupled to another site with high a⁄nity on the inner mem-
brane surface. The low-a⁄nity outside-facing site seems only
accessible in the ADP/vanadate-trapped LmrA suggesting that
the conversion between these two sites depends on ATP hy-
drolysis [11]. X-ray crystallography of MsbA [15] also sug-
gests that tertiary rearrangements of the transmembrane do-
main of MDR-ABC transporters mediated by the ATPase
activity are implicated in their transport mechanism.
Our study provides evidence that the transmembrane seg-
ments of LmrA are not static during the transport cycle, as
expected for a membrane transporter whose function requires
conformational £exibility [11]. Previous experiments indicated
that the H/D exchange of other membrane-embedded helices
of integral membrane proteins, such as lactose permease [38]
or the erythrocyte glucose transporter [39], is fast. Membrane-
embedded helices of integral membrane proteins, such as bac-
teriorhodopsin [40], EmrE [41] and SliK [42], however, display
slow exchange rates. How £exibility of membrane proteins is
related to their biological function is still a matter of debate.
In a second step, we demonstrated that a structural cou-
pling between the cytosolic and membrane-embedded do-
mains of LmrA exists which probably allows the cross-talk
between the ATPase activity in the cytosolic NBD and drug
Fig. 4. Tryptophan quenching by acrylamide: Stern^Volmer plots. F
is the measured £uorescence intensity and F0 is the £uorescence in-
tensity in the absence of acrylamide. b, no substrate added; S,
DNR; 8, MgATPQS+DNR; R, DNR+MgATP. The curves are
the means of at least three experiments. The error bars represent
the standard deviation.
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transport from the lipid bilayer to the external medium. In-
deed, on the one hand, the membrane-embedded domain of
LmrA undergoes dynamic changes mediated by the ATPase
activity. These changes do not modify the mean tilt of the
transmembrane helices and consequently may be due to their
rotation or translation. Rotation may indeed explain how the
substrate binding site of LmrA can be alternately exposed to
the lipid phase and then the aqueous phase before the drug is
released to the extracellular medium. A restructuring of the
transmembrane K-helices of Pgp during the ATPase cycle has
also been observed on two-dimensional crystals and by using
cross-linking experiments [20,34]. A rotational model was also
proposed to explain these data. We observed that the ATPase
activity of LmrA mediates at least two distinct restructurings
of the membrane-embedded K-helices, one due to ATP bind-
ing and another due to ATP hydrolysis. A similar conclusion
was reached from two-dimensional crystals of Pgp [20].
Rosenberg et al. proposed in [20] that ATP binding in the
NBD induces a major conformational change reducing the
a⁄nity for substrate. This hypothesis is corroborated by ra-
dioligand binding assay [43]. They further suggested that after
ATP binding, the drug binding site is reoriented towards the
external medium. We observed that H/D exchange kinetics of
LmrA are similar before and after ATP binding. This seems to
be in contradiction with the opening of a large chamber to-
wards the external medium. ATP hydrolysis, however, medi-
ates a drastic change in the H/D exchange kinetics of the
transmembrane segments. Consequently, we propose that if
ATP binding induces a decrease in drug a⁄nity, ATP hydro-
lysis mediates the reorientation of the drug binding site to-
wards the external medium. Similar conclusions were obtained
from ATR-FTIR experiments on Pgp [44].
We also demonstrated that the cytosolic regions of LmrA,
containing the NBD and loops, undergo conformational
changes during the transport process. First, DNR binding
a¡ects the accessibility of these cytosolic segments to the
aqueous environment. It is likely that DNR-mediated stimu-
lation of the ATPase activity is related to this conformational
modi¢cation. These observations demonstrate that the cross-
talk between the membrane-embedded and cytosolic regions
occurs in both directions. Moreover, ATP binding and hydro-
lysis increase the accessibility towards the solvent of some
cytosolic regions of LmrA. Several experiments including the
crystal structure determination of the ATP binding domain of
HisP [15] and £uorescence measurements on Pgp [45,46] have
demonstrated that the NBD domain of ABC proteins is
highly apolar and it is likely that the NBD of LmrA is mainly
organized as a hydrophobic pocket. Consequently, the highly
accessible conformation reached by some cytosolic segments
of LmrA in the presence of nucleotides probably does not
involve the NBD itself but some cytosolic loops. We deduce
that some intracellular loops may function as a conduit cou-
pling ATP hydrolysis by NBD to tertiary rearrangements of
the £exible transmembrane helices.
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